The GPI-anchored 6-Cys Protein Pv12 is Present in Detergent-resistant Microdomains of Plasmodium vivax Blood Stage Schizonts

Protist

Volumn 164, Issue 1, 2013, Pages 37-48

  Moreno Pérez, Darwin A ^a,b   Areiza Rojas, Rafael ^a   Flórez Buitrago, Ximena ^a   Silva, Yolanda ^a   Patarroyo, Manuel E ^a,c   Patarroyo, Manuel A ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

6 Cys domain; Antigen; Detergent resistant membrane; Glycosylphosphatidylinositol anchor; Malaria; Plasmodium vivax.

Indexed keywords

PARASITE ANTIGEN; PROTOZOAL DNA; PROTOZOAL PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL MEMBRANE; CHEMISTRY; DNA SEQUENCE; ERYTHROCYTE; GENETICS; HAPLORHINI; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PARASITOLOGY; PLASMODIUM VIVAX; PROTEIN TERTIARY STRUCTURE; SCHIZONT; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; DNA, PROTOZOAN; ERYTHROCYTES; HAPLORHINI; MEMBRANE MICRODOMAINS; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; SCHIZONTS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

PLASMODIUM VIVAX;

EID: 84872275577     PISSN: 14344610     EISSN: 16180941     Source Type: Journal    
DOI: 10.1016/j.protis.2012.03.001     Document Type: Article

References (50)

1. Andrysiak P.M., Collins W.E., Campbell G.H. Concentration of Plasmodium ovale- and Plasmodium vivax-infected erythrocytes from nonhuman primate blood using Percoll gradients. Am J Trop Med Hyg 1986, 35:251-254.
2. Arevalo-Pinzon G., Curtidor H., Patino L.C., Patarroyo M.A. PvRON2, a new Plasmodium vivax rhoptry neck antigen. Malaria J 2011, 10:60.
3. Arevalo-Pinzon G., Curtidor H., Vanegas M., Vizcaino C., Patarroyo M.A., Patarroyo M.E. Conserved high activity binding peptides from the Plasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro invasion of red blood cells. Peptides 2010, 31:1987-1994.
4. Bendtsen J.D., Nielsen H., von Heijne G., Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340:783-795.
5. Bozdech Z., Mok S., Hu G., Imwong M., Jaidee A., Russell B., Ginsburg H., Nosten F., Day N.P., White N.J., Carlton J.M., Preiser PR The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci USA 2008, 105:16290-16295.
6. Bradley P.J., Ward C., Cheng S.J., Alexander D.L., Coller S., Coombs G.H., Dunn J.D., Ferguson D.J., Sanderson S.J., Wastling J.M., Boothroyd JC Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J Biol Chem 2005, 280:34245-34258.
7. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E., Crabtree J., Angiuoli S.V., Merino E.F., Amedeo P., Cheng Q., Coulson R.M., Crabb B.S., Del Portillo H.A., Essien K., Feldblyum T.V., Fernandez-Becerra C., Gilson P.R., Gueye A.H., Guo X., Kang'a S., Kooij T.W., Korsinczky M., Meyer E.V., Nene V., Paulsen I., White O., Ralph S.A., Ren Q., Sargeant T.J., Salzberg S.L., Stoeckert C.J., Sullivan S.A., Yamamoto M.M., Hoffman S.L., Wortman J.R., Gardner M.J., Galinski M.R., Barnwell J.W., Fraser-Liggett CM Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
8. Carter R., Coulson A., Bhatti S., Taylor B.J., Elliott J.F. Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12. Mol Biochem Parasitol 1995, 71:203-210.
9. Chuangchaiya S., Jangpatarapongsa K., Chootong P., Sirichaisinthop J., Sattabongkot J., Pattanapanyasat K., Chotivanich K., Troye-Blomberg M., Cui L., Udomsangpetch R. Immune response to Plasmodium vivax has a potential to reduce malaria severity. Clin Exp Immunol 2009, 160:233-239.
10. Cohen S., McGregor I.A., Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
11. del Portillo H.A., Longacre S., Khouri E., David P.H. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc Natl Acad Sci USA 1991, 88:4030-4034.
12. Deleage G., Combet C., Blanchet C., Geourjon C. ANTHEPROT: an integrated protein sequence analysis software with client/server capabilities. Comput Biol Med 2001, 31:259-267.
13. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., Lwin K.M., Ariey F., Hanpithakpong W., Lee S.J., Ringwald P., Silamut K., Imwong M., Chotivanich K., Lim P., Herdman T., An S.S., Yeung S., Singhasivanon P., Day N.P., Lindegardh N., Socheat D., White N.J. Artemisinin resistance in Plasmodium falciparum malaria. New Engl J Med 2009, 361:455-467.
14. Figtree M., Lee R., Bain L., Kennedy T., Mackertich S., Urban M., Cheng Q., Hudson B.J. Plasmodium knowlesi in human, Indonesian Borneo. Emerg Infect Dis 2010, 16:672-674.
15. Garcia J., Curtidor H., Pinzon C.G., Vanegas M., Moreno A., Patarroyo M.E. Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine 2009, 27:3953-3962.
16. Garzon-Ospina D., Romero-Murillo L., Tobon L.F., Patarroyo M.A. Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates. Infect Genet Evol 2011, 11:528-531.
17. Giraldo M.A., Arevalo-Pinzon G., Rojas-Caraballo J., Mongui A., Rodriguez R., Patarroyo M.A. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection. Vaccine 2009, 28:7-13.
18. Houghten R.A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 1985, 82:5131-5135.
19. Hunt R.H., Fuseini G., Knowles S., Stiles-Ocran J., Verster R., Kaiser M.L., Choi K.S., Koekemoer L.L., Coetzee M. Insecticide resistance in malaria vector mosquitoes at four localities in Ghana, West Africa. Parasit Vectors 2011, 4:107.
20. Hunter S., Apweiler R., Attwood T.K., Bairoch A., Bateman A., Binns D., Bork P., Das U., Daugherty L., Duquenne L., Finn R.D., Gough J., Haft D., Hulo N., Kahn D., Kelly E., Laugraud A., Letunic I., Lonsdale D., Lopez R., Madera M., Maslen J., McAnulla C., McDowall J., Mistry J., Mitchell A., Mulder N., Natale D., Orengo C., Quinn A.F., Selengut J.D., Sigrist C.J., Thimma M., Thomas P.D., Valentin F., Wilson D., Wu C.H., Yeats C. InterPro: the integrative protein signature database. Nucleic Acids Res 2009, 37:D211-D215.
21. Kuzniar A., van Ham R.C., Pongor S., Leunissen J.A. The quest for orthologs: finding the corresponding gene across genomes. Trends Genet 2008, 24:539-551.
22. Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, Ha KS, Cao J, Torii M, Sattabongkot J, Tsuboi T, Han ET (2012) Pv12, A 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry. Parasitol Int, (in press). doi:10.1016/j.parint.2012.02.008.
23. Lundquist R., Nielsen L.K., Jafarshad A., Soesoe D., Christensen L.H., Druilhe P., Dziegiel MH Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties. Infect Immun 2006, 74:3222-3231.
24. Mazumdar S., Mukherjee P., Yazdani S.S., Jain S.K., Mohmmed A., Chauhan V.S. Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response. Infect Immun 2010, 78:872-883.
25. Mendis K., Sina B.J., Marchesini P., Carter R The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001, 64:97-106.
26. Mongui A., Angel D.I., Guzman C., Vanegas M., Patarroyo M.A. Characterisation of the Plasmodium vivax Pv38 antigen. Biochem Biophys Res Commun 2008, 376:326-330.
27. Mongui A., Angel D.I., Gallego G., Reyes C., Martinez P., Guhl F., Patarroyo M.A. Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34). Vaccine 2009, 28:415-421.
28. Moreno-Perez D.A., Montenegro M., Patarroyo M.E., Patarroyo M.A. Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1). Malaria J 2011, 10:314.
29. Obando-Martinez A.Z., Curtidor H., Arevalo-Pinzon G., Vanegas M., Vizcaino C., Patarroyo M.A., Patarroyo M.E. Conserved high activity binding peptides are involved in adhesion of two detergent-resistant membrane-associated merozoite proteins to red blood cells during invasion. J Med Chem 2010, 53:3907-3918.
30. Panichakul T., Sattabongkot J., Chotivanich K., Sirichaisinthop J., Cui L., Udomsangpetch R. Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int J Parasitol 2007, 37:1551-1557.
31. Patarroyo M.E., Patarroyo M.A. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Acc Chem Res 2008, 41:377-386.
32. Patarroyo M.E., Bermudez A., Patarroyo M.A. Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development. Chem Rev 2011, 111:3459-3507.
33. Perez-Leal O., Sierra A.Y., Barrero C.A., Moncada C., Martinez P., Cortes J., Lopez Y., Salazar L.M., Hoebeke J., Patarroyo M.A. Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue. Biochem Biophys Res Commun 2005, 331:1178-1184.
34. Perez-Leal O., Sierra A.Y., Barrero C.A., Moncada C., Martinez P., Cortes J., Lopez Y., Torres E., Salazar L.M., Patarroyo M.A. Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation. Biochem Biophys Res Commun 2004, 324:1393-1399.
35. Pico de Coana Y., Rodriguez J., Guerrero E., Barrero C., Rodriguez R., Mendoza M., Patarroyo M.A. A highly infective Plasmodium vivax strain adapted to Aotus monkeys: quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development. Vaccine 2003, 21:3930-3937.
36. Poisson G., Chauve C., Chen X., Bergeron A. FragAnchor: a large-scale predictor of glycosylphosphatidylinositol anchors in eukaryote protein sequences by qualitative scoring. Genom Proteom Bioinform 2007, 5:121-130.
37. Pradel G. Proteins of the malaria parasite sexual stages: expression, function and potential for transmission blocking strategies. Parasitology 2007, 134:1911-1929.
38. Richie T.L., Saul A. Progress and challenges for malaria vaccines. Nature 2002, 415:694-701.
39. Sanders P.R., Gilson P.R., Cantin G.T., Greenbaum D.C., Nebl T., Carucci D.J., McConville M.J., Schofield L., Hodder A.N., Yates J.R., Crabb B.S. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. J Biol Chem 2005, 280:40169-40176.
40. Sherman I.W. Malaria: Parasite Biology, Pathogenesis, and Protection 1998, ASM Press, Washington DC, xiii, 575 p.
41. Sierra A.Y., Barrero C.A., Rodriguez R., Silva Y., Moncada C., Vanegas M., Patarroyo M.A. Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides. Vaccine 2003, 21:4133-4144.
42. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
43. Taylor R.R., Allen S.J., Greenwood B.M., Riley E.M. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg 1998, 58:406-413.
44. Teka H., Petros B., Yamuah L., Tesfaye G., Elhassan I., Muchohi S., Kokwaro G., Aseffa A., Engers H. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Malaria J 2008, 7:220.
45. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
46. Udomsangpetch R., Somsri S., Panichakul T., Chotivanich K., Sirichaisinthop J., Yang Z., Cui L., Sattabongkot J. Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitol Int 2007, 56:65-69.
47. van Dijk M.R., Janse C.J., Thompson J., Waters A.P., Braks J.A., Dodemont H.J., Stunnenberg H.G., van Gemert G.J., Sauerwein R.W., Eling W. A central role for P48/45 in malaria parasite male gamete fertility. Cell 2001, 104:153-164.
48. van Dijk M.R., van Schaijk B.C., Khan S.M., van Dooren M.W., Ramesar J., Kaczanowski S., van Gemert G.J., Kroeze H., Stunnenberg H.G., Eling W.M., Sauerwein R.W., Waters A.P., Janse C.J. Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility. PLoS Pathog 2010, 6:e1000853.
49. Wang L., Richie T.L., Stowers A., Nhan D.H., Coppel R.L. Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam. Infect Immun 2001, 69:4390-4397.
50. WHO (2011) World Malaria Report. WHO Global Malaria Programme.